2-[2-[3-[2-(1,3-benzodioxol-5-yloxy)ethyl-methylamino]propoxy]-5-methoxyphenyl]-4-methyl-1,4-benzothiazin-3-one
-
![2-[2-[3-[2-(1,3-benzodioxol-5-yloxy)ethyl-methylamino]propoxy]-5-methoxyphenyl]-4-methyl-1,4-benzothiazin-3-one structure](https://file.echemi.com/fileManage/upload/canonicalSmiles/20220812/0dc79993b7274422bfde0d6fa6cee9ad.png "2-[2-[3-[2-(1,3-benzodioxol-5-yloxy)ethyl-methylamino]propoxy]-5-methoxyphenyl]-4-methyl-1,4-benzothiazin-3-one")
2-[2-[3-[2-(1,3-benzodioxol-5-yloxy)ethyl-methylamino]propoxy]-5-methoxyphenyl]-4-methyl-1,4-benzothiazin-3-one
structure -
-
CAS No:
116476-16-5
-
Formula:
C29H32N2O6S
-
Chemical Name:
2-[2-[3-[2-(1,3-benzodioxol-5-yloxy)ethyl-methylamino]propoxy]-5-methoxyphenyl]-4-methyl-1,4-benzothiazin-3-one
-
Synonyms:
3,4-dihydro-2-(5-methoxy-2-(3-(N-methyl-N-(2-((3,4-methylenedioxy)phenoxy)ethyl)amino)propoxy)phenyl)-4-methyl-3-oxo-2H-1,4-benzothiazine;levosemotiadil;SA 3212;SA-3212;SD 3211;SD 3212;SD-3211;SD-3212;semotiadil;semotiadil fumarate;sesamodil;sesamodil fumarate;Sesamodil;2H-1,4-Benzothiazin-3(4H)-one, 2-[2-[3-[[2-(1,3-benzodioxol-5-yloxy)ethyl]methylamino]propoxy]-5-methoxyphenyl]-4-methyl-, (2R)-, (2E)-2-butenedioate (1:1) (9CI);CHEMBL56364;SCHEMBL678676;116476-16-5;DB-041318;FT-0631083;(+)-3,4-Dihydro-2-[5-methoxy-2-[3-[methyl[2-[(1,3-benzodioxol-5-yl)oxy]ethyl]amino]propoxy]phenyl]-4-methyl-2H-1,4-benzothiazin-3-one;2-[2-[3-[N-[2-(3,4-Methylenedioxyphenoxy)ethyl]methylamino]propyloxy]-5-methoxyphenyl]-4-methyl-4H-1,4-benzothiazin-3(2H)-one
-
CAS No:
2-[2-[3-[2-(1,3-benzodioxol-5-yloxy)ethyl-methylamino]propoxy]-5-methoxyphenyl]-4-methyl-1,4-benzothiazin-3-one Basic Attributes
536.6 g/mol
536.19810792 g/mol
Drug Information
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)|A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
3,4-dihydro-2-(5-methoxy-2-(3-(N-methyl-N-(2-((3,4-methylenedioxy)phenoxy)ethyl)amino)propoxy)phenyl)-4-methyl-3-oxo-2H-1,4-benzothiazine
Computed Properties
Molecular Weight:536.6
XLogP3:5.1
Hydrogen Bond Acceptor Count:8
Rotatable Bond Count:11
Exact Mass:536.19810792
Monoisotopic Mass:536.19810792
Topological Polar Surface Area:95
Heavy Atom Count:38
Complexity:761
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Request for Quotation